Validation of the ELN2024 less-intensive prognostic stratification in newly diagnosed AML patients receiving venetoclax-azacitidine: A real-world study from China
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Weiguang Cui, Yaxuan Lv, Liyuan Li, Nan Zhou, Zhenzhen Wang, Fan Yang, Mengying Zheng, Xiaoyan Zhang, Li Sun, Jianmin Luo, Lin Yang
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108467993
Cites:
Cited by:
Related to: